戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 1/2, human herpesvirus 8, hepatitis E virus, parvovirus B19).
2 virus, rubella, measles, papillomavirus, and parvovirus B19.
3 hrovirus and is closely related to the human parvovirus B19.
4 a highly efficient systemic dissemination of parvovirus B19.
5 s and allow beta1 integrin-mediated entry of parvovirus B19.
6 een reported to be the cellular receptor for parvovirus B19.
7 reported to be the cell surface receptor for parvovirus B19, a number of nonerythroid cells, which ex
8 ere detected in EMBs from 37 (39%) patients; parvovirus B19, adenovirus, and Epstein-Barr virus (EBV)
9           The structures of infectious human parvovirus B19 and empty wild-type particles were determ
10 recent studies investigating the presence of parvovirus B19 and herpesviruses in temporal arteries wi
11 d confirmatory study, livers were tested for parvovirus B19 and its variant erythroviruses, V9 and A6
12 wo human parvoviruses, namely the pathogenic parvovirus B19 and the nonpathogenic adeno-associated vi
13                        Infections with human parvoviruses B19 and recently discovered human bocavirus
14 ing three invasive Group A streptococci, two parvovirus B19, and one each of HIV-1, measles virus, My
15  and therapeutic utility of the knowledge of parvovirus B19 as the likely etiologic link between the
16  antibodies to nonstructural protein NS-1 in parvovirus B19-associated arthritis have been detected.
17 hat of Aleutian mink disease virus and human parvovirus B19, autonomous members of the genus, despite
18                                              Parvovirus B19 (B19 virus) can persist in multiple tissu
19             Persistent infections with human parvovirus B19 (B19) associated with debilitating chroni
20                                              Parvovirus B19 (B19) can cause acute arthritis, and occa
21                                              Parvovirus B19 (B19) can cause chronic anemia due to per
22                                              Parvovirus B19 (B19) DNA was detected by dot blot hybrid
23                                        Human parvovirus B19 (B19) IgG was studied retrospectively in
24    We evaluated the prevalence of persistent parvovirus B19 (B19) infection and associated anemia in
25                  We analyzed the response to parvovirus B19 (B19), a ubiquitous and clinically signif
26 rpes virus 6B and 7, Epstein-Barr virus, and parvovirus B19 (B19V) across various tissue groups.
27  the main replication protein, NS1, of human parvovirus B19 (B19V) are presented here.
28 ive Finnish casualties from World War II for parvovirus B19 (B19V) DNA, and found a remarkable preval
29                               The pathogenic parvovirus B19 (B19V) has an extreme tropism for human e
30                                 Intrauterine parvovirus B19 (B19V) infection can be asymptomatic or m
31                                              Parvovirus B19 (B19V) infection can cause hematological
32                                              Parvovirus B19 (B19V) infection causes diseases in human
33 lates viral DNA replication.IMPORTANCE Human parvovirus B19 (B19V) infection causes hematological dis
34                                        Human parvovirus B19 (B19V) infection has a unique tropism to
35                                              Parvovirus B19 (B19V) infection is highly restricted to
36                                        Human parvovirus B19 (B19V) infection is restricted to erythro
37                        Accurate diagnosis of parvovirus B19 (B19V) infection requires the differentia
38                                        Human parvovirus B19 (B19V) infection shows a strong erythroid
39                                              Parvovirus B19 (B19V) infects human erythroid progenitor
40                                        Human parvovirus B19 (B19V) is a common pathogen in microvascu
41                                              Parvovirus B19 (B19V) is a member of the family Parvovir
42                                        Human parvovirus B19 (B19V) is a member of the genus Erythrovi
43                                              Parvovirus B19 (B19V) is pathogenic for humans and has a
44                                        Human parvovirus B19 (B19V) is the only human pathogenic parvo
45                                              Parvovirus B19 (B19V) nonstructural protein, NS1, a heli
46 ng of the precursor mRNA (pre-mRNA) of human parvovirus B19 (B19V) plays a key role in posttranscript
47                    Alternative processing of parvovirus B19 (B19V) pre-mRNA is critical to generating
48                     Lytic infection of human parvovirus B19 (B19V) takes place exclusively in human e
49 em has limited high-resolution structures of parvovirus B19 (B19V) to virus-like particles (VLPs).
50 irus 1 (HSV-1), human herpesvirus 6 (HHV-6), parvovirus B19 (B19V), BK polyomavirus (BKPyV), human ad
51 more conformational antigens to detect human parvovirus B19 (B19V)-specific immunoglobulin M (IgM) or
52 Asymptomatic blood donors can transmit human parvovirus B19 (B19V).
53 an erythroleukemia cells (K562), which allow parvovirus B19 binding but not entry.
54 e documented that P antigen is necessary for parvovirus B19 binding but not sufficient for virus entr
55 igen, but not alpha 5 beta 1 integrins, bind parvovirus B19 but do not allow viral entry.
56               Recent studies have shown that parvovirus B19 can cause acute arthritis and occasionall
57 s the potential as an effective antiviral of parvovirus B19 caused hematological disorders, as well a
58                         Infection with human parvovirus B19 causes fifth disease, acute and chronic r
59            The closely related erythrovirus, parvovirus B19, causes anemia in susceptible humans and
60 rus, Toxoplasma gondii, rubella virus, human parvovirus B19, Chlamydia trachomatis, or human papillom
61 ial fibroblasts were treated with or without parvovirus B19-containing human sera for 7 days.
62                              Incubation with parvovirus B19-containing serum induced an invasive phen
63 ns (such as syphillis, varicella-zoster, and parvovirus B19), cytomegalovirus, and herpes simplex vir
64 oinfection with HBV, and 1 case each of HBV, parvovirus B19, cytomegalovirus, and human herpesvirus 7
65 regnant Ghanaian women were tested for human parvovirus B19 DNA and B19-specific antibodies.
66 isco, Calif.) for real-time PCR detection of parvovirus B19 DNA by retesting 71 specimens previously
67                                              Parvovirus B19 DNA has been detected in studies in the s
68  significant difference in the prevalence of parvovirus B19 DNA in livers from patients with FH or HA
69                          In the first study, parvovirus B19 DNA was detected by nested polymerase cha
70       Unexpected viruses identified included parvovirus B19, enterovirus D68, coxsackievirus A16 and
71  antigen is necessary but not sufficient for parvovirus B19 entry into cells, and (iv) parvovirus B19
72 562 cells become adherent and permissive for parvovirus B19 entry, which is mediated by alpha 5 beta
73 llowed us to reconstruct three ancient human parvovirus B19 genomes and one ancient human hepatitis B
74  knowledge of the crystal structure of human parvovirus B19 (genus Erythrovirus).
75                                              Parvovirus B19 has been implicated in some cases of acut
76                                              Parvovirus B19 has been proposed as an etiologic agent o
77                                              Parvovirus B19 has been proposed as the etiological agen
78 gene polymorphisms have been associated with parvovirus B19, hepatitis C virus, HIV-1/AIDS infection,
79 ure red cell aplasia (PRCA) related to human parvovirus B19 (HPV-B19) infection.
80 er rash-causing infections, such as measles, parvovirus B19, human herpesvirus 6, and enteroviruses i
81                                              Parvovirus B19 immunoglobulin M positivity was associate
82 irst-trimester serum samples were tested for parvovirus B19 immunoglobulin M positivity.
83 temporary genotypes of hepatitis B virus and parvovirus B19 in ancient human remains demonstrate that
84 gnostic assays, we discovered an outbreak of parvovirus B19 in dengue-suspected patients that occurre
85                 We studied the prevalence of parvovirus B19 in liver-tissue samples from patients wit
86 tential involvement of, cytomegalovirus, and parvovirus B19 in SSc pathogenesis.
87 her examine the role of the host response to parvovirus B19 in the development of symptoms and conseq
88 mens from individuals with lupus (n = 16) or parvovirus B19 infection (n = 6) or specimens containing
89 ate to combat B19V infection.IMPORTANCEHuman parvovirus B19 infection causes severe hematological dis
90                                      Because parvovirus B19 infection during pregnancy has been assoc
91                         In conclusion, acute parvovirus B19 infection during the first trimester of p
92         Our knowledge of the consequences of parvovirus B19 infection has broadened to include the va
93                                              Parvovirus B19 infection in adults is often associated w
94 e VP1 has a high efficiency in inhibition of parvovirus B19 infection of human erythroid progenitors,
95 oglobulin (IVIg) in the treatment of chronic parvovirus B19 infection, this therapy can cure some of
96 e development of symptoms during acute human parvovirus B19 infection, we compared human leukocyte an
97 pure red cell aplasia resulting from chronic parvovirus B19 infection.
98 ch express P antigen, are not permissive for parvovirus B19 infection.
99 er of reports of myocarditis associated with parvovirus B19 infection.
100  measured in the sera of patients with acute parvovirus B19 infections (n = 12), in those with other
101 n HLA-A*2402-positive individuals with acute parvovirus B19 infections made vigorous CD8-positive cyt
102 e cellular coreceptor for efficient entry of parvovirus B19 into human cells.
103 e neighboring VP2 capsid proteins.IMPORTANCE Parvovirus B19 is a common human pathogen and a particul
104                                              Parvovirus B19 is a long-known human pathogen, whereas a
105                                              Parvovirus B19 is a typical childhood infection, yet we
106 , NS1, from the human-pathogenic virus human parvovirus B19 is presented here.
107          Replication of the pathogenic human parvovirus B19 is restricted to erythroid progenitor cel
108                                        Human parvovirus B19 is the cause of several distinct clinical
109                                        Human parvovirus B19 is the only parvovirus known to be a huma
110               We evaluated the artus RealArt Parvovirus B19 LC PCR reagent (artus biotech USA, San Fr
111 tive ANLL samples bound both shiga toxin and parvovirus B19 on HPTLC immunostaining.
112                                              Parvovirus B19, one of the most common human pathogens,
113 P<.0001) alleles was significantly higher in parvovirus B19 patients than in control subjects.
114 cluding human papillomavirus 16 (HPV-16) and parvovirus B19 (PB-19), with a picomolar sensitivity.
115 ly 0.1% of fetal losses were attributable to parvovirus B19 positivity, a proportion which could incr
116 ncluding transplant recipients infected with parvovirus B19 (PV B19).
117    Expression of globotetraosylceramide, the parvovirus B19 receptor, on myeloblasts may also explain
118                         Cryoglobulinemia and parvovirus B19 serologic results were negative for all t
119                                              Parvovirus B19-seronegative adults (n=24) received eithe
120                                        Human parvovirus B19 shows remarkable tropism for human erythr
121                 The viruses studied included parvovirus B19, six herpesviruses, Merkel cell (MCPyV) a
122  capsids, or virus-like particles (VLPs), of parvovirus B19 that carry dengue 2-specific epitopes wer
123 wareness of co-circulating pathogens such as parvovirus B19 that may be hidden in plain sight.
124                                              Parvovirus B19, the only known human pathogenic parvovir
125                                   Like human parvovirus B19, this virus has a predilection for erythr
126  of cell types and is involved in binding of parvovirus B19 to human cells, (ii) the level of P antig
127 ide direct evidence regarding the ability of parvovirus B19 to induce invasive properties in normal h
128 everse-transcriptase PCR for the presence of parvovirus B19 transcripts as a marker of viral replicat
129  (HBV) or hepatitis C virus (HCV) infection; parvovirus B19 transcripts were not detected.
130 biopsy, explant, or autopsy was analyzed for parvovirus B19 using primers designed to amplify a 699-b
131                              To test whether parvovirus B19 utilizes a cell surface coreceptor for en
132                          A recombinant human parvovirus B19 vaccine (MEDI-491; MedImmune) composed of
133 s of infection with hepatitis B virus (HBV), parvovirus B19, variola virus (VARV), and Mycobacterium
134 or parvovirus B19 entry into cells, and (iv) parvovirus B19 vectors can be used to transduce HUVEC an
135 ave described the development of recombinant parvovirus B19 vectors with which high-efficiency, eryth
136 an enzyme immunoassay that detects the human parvovirus B19 virus (B19V) immunoglobulin M (IgM) or Ig
137 pectrum of the acute polyarthritis caused by parvovirus B19 was further delineated and was shown to i
138 rospective Southern analyses to detect human parvovirus B19 was performed in the 27 patients for whom
139      Human erythrovirus genotype 1 (formerly parvovirus B19) was prevalent in the United Kingdom, Mal
140 parvovirus (SPV), an Erythrovirus similar to Parvovirus B19, was investigated.

 
Page Top